User:Jeremy S. Myers

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(Publications)
Current revision (10:20, 14 August 2008) (view source)
 
(10 intermediate revisions not shown.)
Line 1: Line 1:
-
<!-- Delete this entire line as part of your first edit of your user page --> {{New user}}
 
-
 
==Contact Info==
==Contact Info==
-
[[Image:OWWEmblem.png|thumb|right|Jeremy S. Myers (an artistic interpretation)]]
+
[[Image:OWWEmblem.png|thumb|right|(an artistic interpretation)]]
*Jeremy S. Myers, Ph.D.
*Jeremy S. Myers, Ph.D.
*AstraZeneca Fellow
*AstraZeneca Fellow
 +
*Advanced Targeted Proteomics Team Leader
*Vanderbilt University School of Medicine
*Vanderbilt University School of Medicine
*Mass Spectrometry Research Center
*Mass Spectrometry Research Center
*Nashville, TN, U.S.A.  
*Nashville, TN, U.S.A.  
-
*[[Special:Emailuser/Jeremy S. Myers|Email me through OpenWetWare]]
+
*jeremy.myers@vanderbilt.edu
-
I work in the Proteomics Research Center at Vanderbilt University. I learned about [[OpenWetWare]] while trying to identify available electronic lab notebook wiki resources, and I've joined to develop and distribute laboratory protocols.
+
for more information visit: http://www.advancedtargetedproteomics.com
==Education==
==Education==
<!--Include info about your educational background-->
<!--Include info about your educational background-->
-
* 2003, Ph.D., Louisiana State University
+
* 2003-2007  Postdoctoral Fellow
-
* 1999, B.S., Bucknell University
+
* 2003  Ph.D., Louisiana State University
 +
* 1999 B.S., Bucknell University
==Research interests==
==Research interests==
<!-- Feel free to add brief descriptions to your research interests as well -->
<!-- Feel free to add brief descriptions to your research interests as well -->
-
# Proteomic Analysis of DNA Damage Response Signaling Pathways
+
# Targeted Mass Spectrometry-based Proteomics
-
# Mass Spectrometry Analysis of Protein Posttranslation Modifications
+
# Targeted Therapeutics
-
==Publications==
+
==Publications (since 2007)==
-
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed -->
+
#Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878
-
<biblio>
+
-
 
+
-
 
+
-
// leave a comment about a paper here
+
-
 
+
-
</biblio>
+
==Useful links==
==Useful links==
*[[OpenWetWare:Welcome|Introductory tutorial]]
*[[OpenWetWare:Welcome|Introductory tutorial]]
*[[Help|OpenWetWare help pages]]
*[[Help|OpenWetWare help pages]]
 +
 +
==Selected Protocols==
 +
*[[Myers:EGFR_IP]]
 +
*[[Myers:synchronization]]

Current revision

Contents

Contact Info

(an artistic interpretation)
(an artistic interpretation)
  • Jeremy S. Myers, Ph.D.
  • AstraZeneca Fellow
  • Advanced Targeted Proteomics Team Leader
  • Vanderbilt University School of Medicine
  • Mass Spectrometry Research Center
  • Nashville, TN, U.S.A.
  • jeremy.myers@vanderbilt.edu

for more information visit: http://www.advancedtargetedproteomics.com

Education

  • 2003-2007 Postdoctoral Fellow
  • 2003 Ph.D., Louisiana State University
  • 1999 B.S., Bucknell University

Research interests

  1. Targeted Mass Spectrometry-based Proteomics
  2. Targeted Therapeutics

Publications (since 2007)

  1. Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878

Useful links

Selected Protocols

Personal tools